According to a recent FiercePharma article, the United States is facing a serious shortage of Adderall and its generics. The combination drug is used to treat attention deficit hyperactivity disorder, commonly referred to as ADHD. The article noted that Lannett Co. and Par Pharmaceuticals are the latest to join the list of companies experiencing a shortage. Other companies facing supply issues include Teva, Amneal Pharmaceuticals, Rhodes Pharmaceuticals, and Sandoz. The unprecedented spike in prescriptions is attributed to both increased diagnoses and more widespread availability through online pharmaceutical startups.
The U.S. is Running Out of Adderall
An increase in Adderall prescriptions has led to supply issues, and two more companies have been added to the list.
Sep 29, 2022
Discover the right packaging solutions for life sciences in Philadelphia
Explore innovative packaging and supply chain solutions for the life sciences at the largest PACK EXPO East in history, March 18–20. Get ideas from 400+ top exhibitors and connect with colleagues and industry experts—all in one convenient location!Read More